期刊文献+

卵巢上皮性癌组织中细胞周期素B1和CDK1的表达 被引量:5

Expressions of Cyclin B1 and CDK1 in epithelial ovarian cancer tissue
下载PDF
导出
摘要 目的:探讨卵巢上皮性癌组织中细胞周期素B1(CyclinB1)和细胞周期蛋白依赖性激酶1(CDK1)的表达及其意义。方法:应用免疫组化SP法检测20例正常卵巢组织、20例卵巢良性上皮性肿瘤组织、40例卵巢上皮性癌组织中CyclinB1和CDK1蛋白的表达。结果:①卵巢上皮性癌组织中CyclinB1和CDK1蛋白的阳性表达率分别为77.5%和90.0%,良性卵巢上皮肿瘤组织分别为25.0%和35.0%,正常卵巢组织分别为5.0%和10.0%,3者相比差异有统计学意义(χ2=33.036,39.568;P<0.001)。②CyclinB1蛋白的表达与卵巢上皮性癌FIGO分期、组织分化和淋巴结转移有关(P<0.05),CDK1蛋白的表达与卵巢上皮性癌临床病理特征无关。结论:CyclinB1和CDK1蛋白在卵巢上皮性癌组织中存在异常高表达,可能在卵巢上皮性癌的早期恶变过程中发挥重要作用。 Aim:To study the expressions and clinical significance of Cyclin B1 and cyclin-dependent kinase 1(CDK1) in the epithelial ovarian cancer(EOC) tissue.Methods:Immunohistochemistry SP method was used to detect the expressions of Cyclin B1 and CDK1 in 20 cases of normal ovarian,20 cases of benign epithelial tumor and 40 cases of EOC tissue.Results:The positive expression rates of Cyclin B1 and CDK1 in EOC tissue were 77.5% and 90.0%,respectively,in benign epithelial tumor were 25.0% and 35.0%,in normal ovarian were 5.0% and 10.0%,and there were statistical differences among the three groups(χ2 = 33.036,39.568;P 〈 0.001).The expression of Cyclin B1 protein in EOC tissue was significantly associated with FIGO stage,histological grade and lymph node metastasis(P 〈 0.05),but that of CDK1 had no association with the clinicopathologic features of EOC.Conclusion:There are over-expressions of Cyclin B1 andCDK1 protein in EOC tissue,and they may play key roles in the early carcinogenesis of EOC.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2012年第4期527-530,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 卵巢上皮性癌 细胞周期素B1 细胞周期蛋白依赖性激酶1 epithelial ovarian cancer Cyclin B1 CDK1
  • 相关文献

参考文献9

  • 1Gavet O, Pines J. Progressive activation of CyclinBI-Cdkl coordinates entry to mitosis[ J]. Dev Cell, 2010,18 (4) :533.
  • 2Liu X, Zhang B, Guo Y, et al. Down-regulation of AP-4 inhibits proliferation, induces cell cycle arrest and promotesapoptosis in human gastric cancer cells [J]. PLoS One, 2012,7 ( 5 ) : e37096.
  • 3齐凤杰,邸金娜,赵树鹏.乳腺癌中组织14-3-3σ和cyclin B1的表达及其临床意义[J].中国肿瘤生物治疗杂志,2011,18(2):211-215. 被引量:3
  • 4宋敬,李越,李琳.肿瘤坏死因子α和细胞周期素D1、B1在宫颈癌中的表达及相互关系[J].中国实用妇科与产科杂志,2011,27(1):45-47. 被引量:4
  • 5Kim SJ, Nakayama S, Miyoshi Y, et al. Determination of the specific activity of CDK1 and CDK2 as a novel prognostic in- dicator for early breast cancer[ J ]. Ann Onco1,2,008,19 (1) :68.
  • 6Zhang C, Elkahloun AG, Robertson M, et al. Loss of cy- toplasmic CDK1 predicts poor survival in human lung canc-er and confers chemotherapeutic resistance[J]. PLoS One, 2011,6(8) :e23849.
  • 7颜伟,张永红,何乐亚,魏欣,陶德定,胡俊波,龚建平.胃癌中CDK1和CDK2的表达及预后意义[J].中国组织化学与细胞化学杂志,2010,19(2):165-167. 被引量:8
  • 8张瑞涛,史惠蓉,刘慧冰,等.卵巢上皮性癌组织中P21WAF1和CDKl的表达[J].郑州大学学报:医学版,2009,44(2):334.
  • 9刘慧冰,史惠蓉,张瑞涛,等.卵巢癌组织中CDKl和CDC25B的表达[J].郑州大学学报:医学版,2009.44(2):312.

二级参考文献36

  • 1张梅,尹晓然,骆云雅,林秀,王梦昌,贺鹏程,李静,郭桂丽,蔡瑞波,刘亚琳.树突细胞介导的独特型瘤苗的体外抗骨髓瘤作用[J].中华血液学杂志,2005,26(10):593-597. 被引量:7
  • 2古翠萍,张沂平.TNF-α抗肿瘤作用机制新进展[J].中国肿瘤,2007,16(2):102-105. 被引量:41
  • 3Hanahan D,Weinberg RA.The hallmark of cancer.Cell,2000,100:57-70.
  • 4Colozza M,Azambuja E,Cardoso F,et al.Proliferative markers as prognostic and predictive tools in early breast cancer:where are we now? Ann oncol,2005,16:1723-1739.
  • 5Keyomarsi K,Tucker SL,Buchholz TA,et al.Cyclin E and survival in patients with breast cancer.N Engl J Med,2002,347:1566-1575.
  • 6Kuhling H,Alm P,Olsson H,et al.Expression of cyclins E,A,and B,and prognosis in lymph node-negative breast cancer.J Pathol,2003,199:424-431.
  • 7Murray A,Hunt T.The cell cycle:an introduction.New York:Oxford University Press,1993.
  • 8Nurse P.Universal control mechanism regulating onset of M-phase.Nature,1990,344:503-508.
  • 9Nurse P.A long twentieth century of cell cycle and beyond.Cell,2000,100:71-78.
  • 10Colozza M,Azambuja E,Cardoso F,et al.Proliferative markers as prognostic and predictive tools in early breast cancer:where are we now? Ann oncol.2005,16:1723-1739.

共引文献13

同被引文献61

  • 1陈长恒.Cdc2基因与细胞周期调控[J].中国实用医药,2007,2(13):105-107. 被引量:8
  • 2吴艳萍,李立平,张颖,刘嘉琳,高伟敏.细胞周期调控分子与肿瘤关系的研究进展[J].军医进修学院学报,2006,27(4):306-308. 被引量:8
  • 3I-Iatakeyama S, Watanabe M, Fujii Y, et al. Targeted destruction of c-Myc by an engineered ubiquitin ligase suppresses cell transforma- tion and tumor formation[ J]. Cancer Res, 2005, 65(17) : 7874- 7879.
  • 4Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome [ J ]. Science, 2002, 298 (5600) : 1912 - 1934.
  • 5Siegel RM. Caspases at the crossroads of immune-cell life and death [J]. Nat Rev Immunol, 2006, 6(4) : 308 -317.
  • 6Contreras JL, Vilatoba M, Eckstein C, et al. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice[J]. Surgery, 2004, 136(2) : 390 - 400.
  • 7Karatas H, Aktas Y, Gursoy-Ozdemir Y, et al. A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection [ J ]. J Neurosci, 2009, 29 ( 44 ) : 13761 - 13769.
  • 8G6mez M, Hernandez ML, Pazos MR, et al. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance [ J ]. Neuroscience, 2008, 153(3) : 687 -699.
  • 9Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer[J]. Nature, 2001,411(6835): 342-348.
  • 10Gavet O, Pines J. Progressive activation of CyclinB1-Cdkl coordinates entry to mitosis[J]. Dev Cell, 2010, 18(4) : 533 -543.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部